Results from the Phase III NRG Oncology NRG-GU003 clinical trial comparing hypofractioned post-prostatectomy radiotherapy (HYPORT) to conventionally fractioned post-prostatectomy radiotherapy (COPORT) ...
For post-prostatectomy radiotherapy (RT), use of a hypofractionated regimen was noninferior to conventional RT in terms of patient-reported gastrointestinal or genitourinary (GI/GU) toxicities, a ...
Polo-like kinase-1 as a potential prognostic marker of prostate cancer utilizing ORIEN data. This is an ASCO Meeting Abstract from the 2023 ASCO Genitourinary Cancers Symposium. This abstract does not ...
The phase 3 MAGNOLIA trial will assess whether abelacimab can prevent venous thromboembolism recurrence in patients with gastrointestinal or genitourinary cancers. Recruitment has started for a phase ...
A Phase II Basket Study of the Oral TRK Inhibitor LOXO-101 in Adult Subjects with NTRK Fusion-Positive Tumors. Background: For patients with advanced genitourinary (GU) and gastrointestinal (GI) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results